15 արդյունքներ
BACKGROUND OF THE INVENTION
Treatment of human cancer is an area of clinical medicine which remains fraught with complications and which often presents an array of suboptimal treatment choices. For example, prostate cancer, which is the most common cancer in men and the second leading cause of
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
BACKGROUND OF THE INVENTION
The incidence of malignant glioma is approximately 12,000 new cases per year. These tumors represent the second leading cause of cancer mortality in people under the age of 35 and the fourth leading cause in
FIELD OF THE INVENTION
The present invention relates to monoterpene or sesquiterpene compositions. In particular, the present invention relates to using monoterpenes (such as (S)-perillyl alcohol) or sesquiterpenes having a purity greater than about 98.5% (w/w) to treat nervous system
FIELD OF THE INVENTION
The present invention relates to monoterpene or sesquiterpene compositions. In particular, the present invention relates to using monoterpenes (such as (S)-perillyl alcohol) or sesquiterpenes having a purity greater than about 98.5% (w/w) to treat nervous system
FIELD OF THE INVENTION
The present invention relates to monoterpene or sesquiterpene compositions. In particular, the present invention relates to using monoterpenes (such as (S)-perillyl alcohol) or sesquiterpenes having a purity greater than about 98.5% (w/w) to treat nervous system
FIELD OF THE INVENTION
The present invention relates to monoterpene or sesquiterpene compositions. In particular, the present invention relates to using monoterpenes (such as (S)-perillyl alcohol) or sesquiterpenes having a purity greater than about 98.5% (w/w) to treat nervous system
FIELD OF THE INVENTION
The present invention relates to monoterpene or sesquiterpene compositions. In particular, the present invention relates to using monoterpenes (such as (S)-perillyl alcohol) or sesquiterpenes having a purity greater than about 98.5% (w/w) to treat nervous system
FIELD OF THE INVENTION
The present invention relates to monoterpene or sesquiterpene compositions. In particular, the present invention relates to using monoterpenes (such as (S)-perillyl alcohol) or sesquiterpenes having a purity greater than about 98.5% (w/w) to treat nervous system
FIELD OF THE INVENTION
The present invention relates to POH derivatives. The present invention further relates to methods of using POH derivatives such as POH carbamates to treat cancer.
BACKGROUND OF THE INVENTION
Malignant gliomas, the most common form of central nervous system (CNS) cancers, is
FIELD OF THE INVENTION
The present invention relates to POH derivatives. The present invention further relates to methods of using POH derivatives such as POH carbamates to treat cancer.
BACKGROUND OF THE INVENTION
Malignant gliomas, the most common form of central nervous system (CNS) cancers, is
FIELD OF THE INVENTION
The present invention relates to POH derivatives. The present invention further relates to methods of using POH derivatives such as POH carbamates to treat cancer.
BACKGROUND OF THE INVENTION
Malignant gliomas, the most common form, of central nervous system (CNS) cancers, is
FIELD OF THE INVENTION
The present invention relates to POH derivatives. The present invention further relates to methods of using POH derivatives such as POH carbamates to treat cancer.
BACKGROUND OF THE INVENTION
Malignant gliomas, the most common form of central nervous system (CNS) cancers, is
FIELD OF THE INVENTION
The present invention relates to POH derivatives. The present invention further relates to methods of using POH derivatives such as POH carbamates to treat cancer.
BACKGROUND OF THE INVENTION
Malignant gliomas, the most common form of central nervous system (CNS) cancers, is
FIELD OF THE INVENTION
The present invention relates to isoperillyl alcohol (iso-POH) and isoperillyl alcohol derivatives. Isoperillyl alcohol includes any isomers or analogs of perillyl alcohol. The present invention further relates to methods of using isoperillyl alcohol and isoperillyl alcohol
FIELD OF THE INVENTION
The present invention relates to isoperillyl alcohol (iso-POH) and isoperillyl alcohol derivatives. Isoperillyl alcohol includes any isomers or analogs of perillyl alcohol. The present invention further relates to methods of using isoperillyl alcohol and isoperillyl alcohol